Women Living With HIV Require Better Mental Health Diagnostics and Interventions
In a narrative review, researchers described various mental health interventions, and their feasibility and outcomes for WLWH.
HIV/AIDS
HIV/AIDS
-
-
HIV and Inflammatory Bowel Disease: A Unique Patient Population
The authors review gut dysfunction and microbiota changes during HIV infection and IBD and discuss how they may induce a dysfunctional mucosal barrier, dysbiosis, and changes on the cellular level, including monocytes, macrophages, and dendritic cells. -
Understanding the Oncogenic Role of HIV in Burkitt Lymphoma
While the rate of certain HIV-linked non-Hodgkin lymphomas has declined since the introduction of ART, the incidence of Burkitt lymphoma has remained steady. -
Neurocognitive Conditions Among People Living With HIV
Neurologic conditions associated with HIV remain major contributors to morbidity and mortality, and are increasingly recognized in the aging population of individuals living with HIV. -
An Overview of HIV-Associated Neurocognitive Disorder
Rates of HIV-associated dementia have decreased from approximately 50% in the pre-cART era to 2% currently. However, roughly 50% of patients treated with cART have the milder forms of HIV-associated neurocognitive disorder (HAND).
Latest News
In Women With HIV, Hot Flashes Linked to Surrogate Markers of Cardiovascular Disease Risk
In this study, researchers explored the relationship between hot flash frequency and systemic immune activation as well as subclinical cardiac pathology among women with HIV.
Increased CVD Risk With ß-Blockers for HTN in Veterans With HIV
Researchers used propensity matching to examine the risk of incident/recurrent CVD or death, incident CVD, and incident heart failure by antihypertensive class among veterans with HIV and incident hypertension.
Early Diagnosis and Treatment of Blacks with HIV Are Especially Needed In Rural Settings
Study authors evaluated care outcomes among black persons diagnosed with HIV during 2018 in rural, urban, and metropolitan areas.
Rosuvastatin Reduces Inflammatory Markers in People With HIV and Metabolic Syndrome
Study authors assessed the effect of statins in patients with HIV and metabolic syndrome, as they are usually associated with systemic inflammation and higher cardiovascular risk.
HIV Infection Increases Risk for Severe COVID-19, COVID-19-Related Mortality
Study authors evaluated the association between HIV diagnosis and COVID-19 diagnosis, hospitalization, and in-hospital death in New York State.
5 Unmet Mental Health Needs of Women Living With HIV
Women living with HIV have a unique set of mental health risks and stressors, but are their needs being met? Healthcare providers should be aware of these 5 ways that women with HIV are experiencing detriments to their mental health.
Early cART Initiation Benefits Children Infected With HIV-1 Perinatally
The researchers’ goal was to compare HIV reservoirs in children aged 5 to 12 years and adolescents aged 13 to 17 years who started combined antiretroviral therapy (cART) before the age of 6 months vs after the age of 2 years.
High Prevalence of HCV Infection in MSM Regardless of HIV Status
The researchers’ objective was to determine the prevalence of HCV antibodies among MSM with and without HIV, as well as factors associated with HCV infection among MSM.
The Rise of Multidrug-Resistant Tuberculosis in HIV Patients
Researchers reviewed existing data to determine the contribution of HIV to MDR-TB worldwide, including the patterns of MDR-TB by age and global region and the trends in MDR-TB infection risks.
Antibody Infusions to Prevent HIV Acquisition
The AMP Studies aimed to establish whether infusions of bNAb called VRC01 are an effective and safe way to prevent HIV acquisition.
Prophylactic Effects of Dolutegravir in Infants With HIV Transmission Risk
Investigators used data from mothers and infants enrolled in the DolPHIN-1 trial to develop a population pharmacokinetic model of dolutegravir.
Individuals With Highest HIV Infection Rates Insured by Medicaid Less Likely to Persist With HIV Pre-Exposure Prophylaxis
Study authors estimated pre-exposure prophylaxis persistence among cohorts of patients with commercial vs Medicaid insurance.
People Living With HIV May Have Worse COVID-19 Outcomes
The acceleration of the COVID-19 pandemic continues to stress health care systems and exacerbate disparities in many communities, highlighting the importance of identifying patients at elevated risk of severe disease for COVID-19 vaccine prioritization.
Protection From HIV With Pre-Exposure Prophylaxis May be Accurately Assessed in Urine Samples
Study authors identified a new tool to support pre-exposure prophylaxis adherence for HIV prevention, primarily in how adequate urine tenofovir levels measured in an immunoassay predicted HIV protection.
Brief, Patient-Reported Engagement Survey Associated With Virologic Control Among Patients With HIV
Study authors investigated the association between a brief, self-reported measure of engagement in HIV care and viral suppression outcomes.
Is Liver Stiffness Seen in HIV Patients a Result of Hepatotoxic Drug Exposure?
Researchers aimed to estimate the prevalence of liver fibrosis and factors associated with it in people living with HIV compared with those in a control group.
Comparing Rates of STIs in Men Before and After Starting HIV PrEP
The researchers sought to determine if access to HIV PrEP was associated with preexisting trends in STIs among high-risk men who have sex with men.
New Test for Diagnosis of Tuberculosis Meningitis in Patients With HIV
A new point-of-care lateral flow assay featured the same sensitivity as mycobacterial culture in detecting tuberculosis meningitis in adults with HIV.
Azithromycin: Some Benefit to Pediatric Patients With HIV-Related Lung Disease
Study authors assessed whether prophylactic azithromycin can prevent worsening of lung function and reduce acute respiratory exacerbations in children with HCLD taking ART.
Cabenuva Approved as First Long-Acting Injectable for HIV Treatment
The approval of Cabenuva was based on data from two phase 3 trials which included 1182 HIV-infected adults who were virologically suppressed (HIV-1 RNA less than 50 copies/mL) prior to initiation.
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
